Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of an Upcoming Lead Plaintiff Deadline on August 17, 2026

Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of an Upcoming Lead Plaintiff Deadline on August 17, 2026

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC) on behalf of investors that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Embecta and have suffered losses, you may CLICK HERE to contact us.

İlgili Semboller 1
EMBC EMBC
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
EquipmentShare.com Inc. Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

EquipmentShare.com Inc. Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in EquipmentShare.com Inc. ("EquipmentShare" or the "Company") (NASDAQ: EQPT) of a class action securities lawsuit.

İlgili Semboller 1
EQPT EQPT
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.

İlgili Semboller 1
ERAS ERAS
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 25, 2026 to file lead plaintiff applications in a securities class action lawsuit against Futu Holdings Limited ("Futu" or the "Company") (NASDAQ: FUTU), if they purchased or otherwise acquired the Company's securities between May 24, 2023 and May 27, 2026, inclusive (the "Class Period").

İlgili Semboller 1
FUTU FUTU
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Healthpeak Properties: The Market Still Underestimates Its Recovery Potential

Healthpeak Properties: The Market Still Underestimates Its Recovery Potential

Healthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoing portfolio pivot despite macro headwinds. DOC delivered a robust Q2, beating FFO and revenue estimates, increasing guidance, and executing $1 billion in asset sales to strengthen liquidity. Valuation remains compelling, with intrinsic value estimated above current levels even under conservative estimates, supported by conservative AFFO growth and a high discount rate.

İlgili Semboller 1
DOC DOC
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and Approximately 31% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and Approximately 31% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hub Group, Inc. ("Hub" or the "Company") (NASDAQ: HUBG), if they purchased or otherwise acquired the Company's securities between April 28, 2023, and May 11, 2026, inclusive (the "Class Period").

İlgili Semboller 1
HUBG HUBG
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
T1 ENERGY: Block & Leviton Investigation Could Help Investors Recover Losses

T1 ENERGY: Block & Leviton Investigation Could Help Investors Recover Losses

Boston, Massachusetts--(Newsfile Corp. - August 7, 2026) - Block & Leviton is investigating T1 Energy (NYSE: TE) for potential securities law violations. Investors who have lost money in their T1 Energy investment should contact the firm to learn more about how they might recover those losses.

İlgili Semboller 1
SQ SQ
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: PRNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm infestations. Elanco also offers producers Negasunt® Powder (coumaphos, propoxur, and sulfanilamide topical powder) and Tanidil®, which received emergency authorizations earlier this year, as well as EPA-registered Catron™ IV.

İlgili Semboller 1
ELAN ELAN
Kaynak: PRNewsWire
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA) of a class action securities lawsuit.

İlgili Semboller 1
ADMA ADMA
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Ocugen's Q2 Earnings Miss Estimates as R&D Costs Rise, Stock Falls

Ocugen's Q2 Earnings Miss Estimates as R&D Costs Rise, Stock Falls

OCGN posts a wider Q2 loss as R&D spending climbs, while advancing late-stage gene therapy programs and extending its cash runway into 2028.

İlgili Semboller 1
OCGN OCGN
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap